Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Fig. 5

Visualization of a sample clinical report. AMLVaran’s clinical reports consist of an overview of the predefined mutation sites. For each site, a color-coded area shows one of three states. Red indicates that a relevant mutation was found in the given area, yellow intervals have no associated mutation, but the coverage is not sufficient to allow a safe exclusion of variants. Finally, the presence of mutations in green areas can reliably be excluded due to good coverage, and lack of mutation evidence. Based on the mutation status and the stored diagnostic rules, the applicable diagnostic information is displayed. Furthermore, an assessment summary can be added by the evaluating pathologist. The report can be augmented with more detailed information for each mutation site, including details on the detected mutations, the coverage in the examined area, and general information on the function of the considered gene

Back to article page